Panel Discussion: Discussing Investment in RNA-Targeting Therapeutics to Accelerate Advancement of Small Molecule Therapies for Patients in Need
Time: 2:00 pm
day: Day Two
Details:
- What motivation do venture capitalists need to invest in RNA targeting small molecule therapeutics?
- What do venture capitalists view as critical points of investment both in preclinical and early clinical development?
- What do investors look for in investable ideas and approaches within the RNA-targeting field?
